Understand the source comparison
Clinical Efficacy: Tesofensine vs GLP-1 Medications
Direct head-to-head trials between tesofensine and semaglutide or tirzepatide don't exist as of 2026, but comparing pivotal trial results shows tesofensine's weight loss magnitude sits between lower-dose GLP-1 therapy and high-dose tirzepatide. The STEP-1 tria
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Direct head-to-head trials between tesofensine and semaglutide or tirzepatide don't exist as of 2026, but comparing pivotal trial results shows tesofensine's weight loss magnitude sits between lower-dose GLP-1 therapy and high-dose tirzepatide. The STEP-1 trial (semaglutide 2.4mg weekly) produced 14.9% mean body weight reduction at 68 weeks. The SURMOUNT-1 trial (tirzepatide 15mg weekly) produced 20.9% at 72 weeks. Tesofensine 1.0mg daily produced 12.8% at 24 weeks. Shorter duration makes direct comparison incomplete, but the rate of loss (approximately 0.5% body weight per week) is comparable to mid-dose semaglutide.
- The critical difference: tesofensine's weight loss didn't depend on dietary structure or glycemic status. GLP-1 medications produce larger absolute weight loss in patients who maintain structured caloric deficits alongside the drug. The medication enhances adherence by suppressing hunger, but it's not thermogenic. Tesofensine's documented 6–10% increase in resting energy expenditure means it burns additional calories independent of activity or food intake. A 180-pound adult with a basal metabolic rate of 1,800 calories would burn an extra 108–180 calories daily on tesofensine without changing behavior.
- For researchers considering alternatives to GLP-1 protocols, tesofensine represents a stimulant-like mechanism without the cardiovascular risk profile of older sympathomimetics like phentermine. However, the dopamine reuptake inhibition raises theoretical addiction liability. Though clinical trials haven't documented abuse or dependence issues at therapeutic doses. You can explore complementary research compounds through our FAT Loss Stack, which includes peptides that support metabolic health through entirely different pathways.